Focused Alpha LLC Purchases 1,555 Shares of UnitedHealth Group Incorporated $UNH

Focused Alpha LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 1,555 shares of the healthcare conglomerate’s stock, valued at approximately $571,000.

Other large investors have also made changes to their positions in the company. Nvwm LLC raised its holdings in UnitedHealth Group by 89.2% in the 3rd quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $26,000 after acquiring an additional 33 shares in the last quarter. Nalls Sherbakoff Group LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $27,000. Wellington Altus USA Inc. increased its position in shares of UnitedHealth Group by 97.1% during the second quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 33 shares during the period. Security National Bank of SO Dak acquired a new position in shares of UnitedHealth Group in the second quarter valued at $29,000. Finally, Aberdeen Wealth Management LLC bought a new position in UnitedHealth Group in the second quarter worth $31,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 0.19% of the stock is currently owned by company insiders.

UnitedHealth Group Trading Up 1.4%

Shares of NYSE UNH opened at $406.99 on Tuesday. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62. The company has a 50-day moving average of $387.04 and a two-hundred day moving average of $386.47. The company has a market cap of $365.31 billion, a PE ratio of 23.24, a P/E/G ratio of 1.45 and a beta of 0.60. The company has a current ratio of 0.74, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. The firm had revenue of $112.70 billion for the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The business’s quarterly revenue was down .4% compared to the same quarter last year. During the same period last year, the company earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 20.64 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were given a dividend of $2.32 per share. The ex-dividend date was Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. UnitedHealth Group’s payout ratio is currently 53.00%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. HSBC increased their price objective on shares of UnitedHealth Group from $300.00 to $380.00 and gave the company a “hold” rating in a research note on Monday, July 6th. JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $516.00 to $524.00 and gave the stock an “overweight” rating in a research report on Friday. New Street Research set a $402.00 price objective on UnitedHealth Group in a report on Friday, October 9th. Robert W. Baird lowered their price objective on UnitedHealth Group from $453.00 to $427.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 14th. Finally, Zacks Research cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Monday, September 14th. Twenty analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $463.57.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q3 earnings beat and higher guidance support the stock. UnitedHealth reported adjusted earnings of $4.69 per share, above the $4.14 consensus estimate, while revenue of $112.7 billion also exceeded expectations. Management raised its 2026 adjusted earnings guidance to at least $20.50 per share, reinforcing confidence in operating performance and medical-cost management. UnitedHealth Group Has The Market Asking A Bigger Question
• Positive Sentiment: Analyst and investor interest has strengthened. Recent momentum following the earnings report has renewed attention on UnitedHealth’s medical-cost trends and execution. A JPMorgan analyst also expects the stock to rise, while healthcare ETF commentary highlights UNH as an attractive holding for diversified sector exposure. UnitedHealth Group Stock Price Expected to Rise
• Neutral Sentiment: AI remains a broader healthcare investment theme. Articles identify artificial intelligence, data-driven testing and biointelligence as growth drivers across healthcare, but the highlighted beneficiaries are primarily Guardant Health, Illumina, Eli Lilly and Moderna rather than UnitedHealth directly. The AI Trade Just Moved Into Your Bloodstream
• Negative Sentiment: Enrollment losses could pressure parts of the insurance business. KFF research shows individual-market enrollment fell 18% to 20.5 million in 2026, with remaining customers facing substantially higher premiums. The impact on UNH may be limited by its broader business mix, but shrinking enrollment is an industry risk. Americans Leave Health Insurance Market
• Negative Sentiment: Medicare Advantage disruption and valuation temper enthusiasm. About 3.2 million seniors may lose their Medicare Advantage plans in 2027, potentially increasing member-retention and regulatory challenges. Separately, one analyst downgraded UNH from “strong buy” to “buy,” arguing that a valuation near 20 times forward earnings already reflects much of the recovery. UnitedHealth Rating Downgrade

UnitedHealth Group Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.